MAP3K8 and neoplasm: Although identified as a target, the frequency of this mutation is still under investigation with one retrospective analysis of spitzoid tumor samples finding that 33% of SM harbor a MAP3K8 fusion and two other cohorts finding only 8% of total Spitz lesions harbor a MAP3K8 fusion (16, 23, 110).